Filana Therapeutics, Inc. Other Non-Current Liabilities
Filana Therapeutics, Inc. (FLNA) had Other Non-Current Liabilities of $111.00 thousand as of 2026-03-31, per its 10-Q filed 2026-05-07.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OtherLiabilitiesNoncurrent · last filed 2026-05-07
- 2026-03-31: Other Liabilities, Noncurrent $111.00K.
- 2025-12-31: Other Liabilities, Noncurrent $118.00K.
- 2025-09-30: Other Liabilities, Noncurrent $119.00K.
- 2025-06-30: Other Liabilities, Noncurrent $79.00K.
| Period end | Other Liabilities, Noncurrent |
|---|---|
| 2026-03-31 | $111.00K 10-Q · filed 2026-05-07 |
| 2025-12-31 | $118.00K 10-Q · filed 2026-05-07 |
| 2025-09-30 | $119.00K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $79.00K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $79.00K 10-Q · filed 2025-05-08 |
| 2024-12-31 | $79.00K 10-K · filed 2026-03-12 |
| 2024-09-30 | $80.00K 10-Q · filed 2024-11-07 |
| 2023-12-31 | $0.00 10-K · filed 2025-03-03 |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-07 |
| 2023-03-31 | $197.00K 10-Q · filed 2023-05-01 |
| 2022-12-31 | $197.00K 10-K · filed 2024-02-28 |
| 2022-09-30 | $197.00K 10-Q · filed 2022-11-07 |
| 2022-06-30 | $201.00K 10-Q · filed 2022-08-04 |
| 2022-03-31 | $194.00K 10-Q · filed 2022-05-05 |
| 2021-12-31 | $194.00K 10-K · filed 2023-02-28 |
| 2021-09-30 | $194.00K 10-Q · filed 2021-11-15 |
| 2011-09-30 | $434.00K 10-Q · filed 2011-11-03 |
| 2011-06-30 | $432.00K 10-Q · filed 2011-08-04 |
| 2010-12-31 | $431.00K 10-Q · filed 2011-11-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |